Everything below concerns evidence gap. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-17. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised material; shade varies slightly between lots |
| Solubility in water | Freely soluble | Dissolves in water, saline, and aqueous buffers |
| Solubility in nonpolar solvents | Poorly soluble | Not compatible with oils or hydrocarbon solvents |
| Typical storage temperature | About −20 °C | Lyophilised, dry, dark storage slows hydrolysis |
| Common purity method | Reversed-phase HPLC | Area percentage, usually paired with mass spectrometry |
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Following the invasion and annexation of Kuwait by Iraq, on September 25, 1990, the Italian Government sent eight multirole fighter bombers Tornado IDS (plus two spare) in the Persian Gulf, belonging to the 6º, 36º and 50º Stormo, which were deployed at the Al Dhafra Air Base, near Abu Dhabi, in the United Arab Emirates. During the 42 days of war, Italian fighters made 226 sorties for a total of 589 flight hours. The Italian Air Force lost one aircraft in the Gulf War. The use of Italian aircraft as part of the Desert Storm operation represented the first operational employment in combat missions of Italian Air Force aircraft since the end of World War II.
Native enteropeptidase and the isolated light chain have similar activity toward Gly-(Asp)4-Lys-NHNap, but the secluded light chain has distinctly decreased activity toward trypsinogen . An analogous selective defect in the recognition of trypsinogen can be produced in two-chain enteropeptidase by heating or by acetylation. This behavior implies that the catalytic center and one or more secondary substrate-binding sites are essential for optimal recognition of trypsinogen.
Modafinil sulfone (code name CRL-41056) is an achiral, oxidized metabolite of modafinil, a wakefulness-promoting agent. It is one of two major circulating metabolites of modafinil, the other being modafinil acid. Modafinil sulfone is also a metabolite of the modafinil prodrug, adrafinil. Modafinil sulfone is also a metabolite of armodafinil, the (R)-(–)-enantiomer of modafinil, as oxidation to the sulfone removes the chiral center at the sulfur atom. Modafinil sulfone has been described as inactive, and similarly to modafinil acid, does not appear to contribute to the wakefulness-promoting effects of modafinil. However, like modafinil, modafinil sulfone was found to show anticonvulsant properties in animals, indicating that it does possess some biological activity.
Narrated by Susan Rae, of Radio 4, produced by Sean McPhilemy, directed by Vivienne King, made by Box Productions 22 December Unravelling the Universe, theological questions about the creation of the universe, and how general relativity can match with quantum theory; with Michael Green of Queen Mary & Westfield College; Paul Davies of the University of Adelaide; Peter Coles of Queen Mary & Westfield College and how Copernicus struggled to fit his model to the Solar System, until Kepler showed that the orbits were elliptical; how Maxwell was the first to properly understand the electromagnetic force from Faraday's earlier work; Christopher Isham of the Blackett Laboratory and how Maxwell's equations did not fit Newton's laws of motion at the start of the 20th century, resulting in Einstein replacing Newton's laws, and gravity with general relativity in 1915, but in practice Newton's laws worked as expected; quantum theory was originated around the same time; Rocky Kolb of Fermilab and how quantum mechanics and gravity (or relativity) produce incompatible results of infinities and mathematical singularities when calculated together, a situation that was attempted to be resolved by superstring theory. Narrated by Peter Jones, directed by David Barlow, written and produced by Chris Haws, made by InCA Productions
Sources: en.wikipedia.org
Roller chain is ordinarily hooked up using a master link (also known as a "connecting link"), which typically has one pin held by a horseshoe clip rather than friction fit, allowing it to be inserted or removed with simple tools. Chain with a removable link or pin is also known as "cottered chain", which allows the length of the chain to be adjusted. Half links (also known as "offsets") are available and are used to increase the length of the chain by a single roller. Riveted roller chain has the master link (also known as a "connecting link") "riveted" or mashed on the ends. These pins are made to be durable and are not removable.
Raw feeding is the practice of feeding domestic dogs, cats and other animals a diet consisting primarily of uncooked meat, edible bones, and organs. The ingredients used to formulate raw diets can vary. Some pet owners choose to make homemade raw diets to feed their animals but commercial raw food diets are also available. Frozen, or fresh-prepared, meals come in raw or cooked form, some of which is made with ingredients that are inspected, approved, and certified by the USDA for human consumption, but formulated for pets. Part of this growing trend is the commercialization of home-made dog food for pet owners who want the same quality, but do not have the time or expertise to make it themselves. The advantage is forgoing the processing stage that traditional dog food undergoes. This causes less destruction of its nutritional integrity. The practice of feeding raw diets has raised some concerns due to the risk of foodborne illnesses, zoonosis and nutritional imbalances. People who feed their dogs raw food do so for a multitude of reasons, including but not limited to: culture, beliefs surrounding health, nutrition and what is perceived to be more natural for their pets. Feeding raw food can be perceived as allowing the pet to stay in touch with their wild, carnivorous ancestry. The raw food movement has occurred in parallel to the change in human food trends for more natural and organic products.
{\displaystyle {\frac {R}{r}}\geq {\frac {abc+a^{3}+b^{3}+c^{3}}{2abc}}\geq {\frac {a}{b}}+{\frac {b}{c}}+{\frac {c}{a}}-1\geq {\frac {2}{3}}\left({\frac {a}{b}}+{\frac {b}{c}}+{\frac {c}{a}}\right)\geq 2.}
Sources: en.wikipedia.org
=== 17 July === The Ukrainian military said that its positions in Krynky had been destroyed by Russian attacks, but denied that it had retreated from the village. However, many sources stated that Ukrainian forces had completely withdrawn from the village. In Donetsk Oblast, Russian forces took the village of Spirne. In Russia, the governor of Belgorod Oblast claimed that two people were killed in a drone strike on the border village of Tserkovny. Russia and Ukraine conducted a prisoner exchange involving 95 POWs on each side following an agreement brokered by the UAE.
In 1994, HCFA stated that in vitro fertilization was categorized as a therapeutic procedure, not a diagnostic procedure, and therefore not covered under CLIA. As such, AAB/ABB took the position that IVF laboratory tests are covered under CLIA, while ASRM and SART took the opposing position. On September 16, 1998, the Clinical Laboratory Improvement Advisory Committee (CLIAC) made a non-binding recommendation that CLIA coverage apply to embryology laboratories and suggested the College of American Pathologists (CAP) and ASRM accreditation checklist. However, the United States Secretary of Health and Human Services Donna Shalala did not implement the recommendation prompting the AAB to sue HHS to force a decision on March 16, 1999. In response, ASRM filed an amicus brief opposing AAB's lawsuit. On March 8, 2000, the lawsuit was dismissed by Thomas F. Hogan due to lack of standing. In 1994, the American Board of Bioanalysis (ABB) created the first CLIA-approved HCLD board exam for andrologists and embryologists.
== In popular culture == In the third chapter of the book Ozempic, la révolution de l'obésité ̶ L’enquête titled A race for patents and Nobel Prizes devoted to Svetlana Mojsov the author Fabrice Delaye summerizes: “In 1982, the identification in animals of the slimming molecule GLP-1 triggered a fierce competition between Danish and American researchers to find it in humans. The race ended in success—but with one casualty: Svetlana Mojsov, a biochemist of Macedonian origin exiled in New York. She was the first to synthesize the molecule that is effective in the human body.” The second chapter, The Discovery—A Murky Area, of the book Off the Scales by Aimee Donnellan is devoted to the fundamental contribution of Svetlana Mojsov to the discovery of GLP-1, the unfair treatment by her collaborators at the Massachusetts General Hospital in Boston and her long plight to be recognized and included in the patents.
=== Attention deficit hyperactivity disorder === Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). It is approved for use in children, adolescents, and adults. However, its efficacy has not been studied in children under six years old. One of the primary differences with the standard stimulant treatments for ADHD is that it has no known misuse potential. Meta-analyses and systematic reviews have found that atomoxetine has comparable efficacy and equal tolerability to methylphenidate in children and adolescents. In adults, efficacy and tolerability are equivalent. The benefits of atomoxetine against ADHD symptoms are dose-dependent until a plateau is reached. While its efficacy may be less than that of lisdexamfetamine, there is some evidence supporting its use in combination with stimulants. Doctors may prescribe non-stimulants including atomoxetine when a person has bothersome side effects from stimulants; when a stimulant was not effective; in combination with a stimulant to increase effectiveness; when the cost of stimulants is prohibitive; or when there is concern about the misuse potential of stimulants in a patient with a history of substance use disorder. Atomoxetine, similarly to stimulants, appears to reduce emotional lability associated with ADHD in adults. Atomoxetine is thought to alleviate ADHD symptoms through norepinephrine reuptake inhibition and by indirectly increasing dopamine levels in the prefrontal cortex, sharing 70–80% of the brain regions with stimulants in its produced effects.
Sources: en.wikipedia.org
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.
Reversed-phase HPLC is the standard approach, with purity expressed as a percentage of total peak area. Mass spectrometry confirms the expected molecular mass and can reveal adducts or truncated sequences. Neither method on its own establishes biological activity.
Small mass differences often reflect different counterions, such as acetate versus trifluoroacetate, or bound water rather than a different amino acid sequence. Mass spectrometry can distinguish these forms when the ionisation conditions are known. Exact sequence confirmation requires peptide mapping or tandem mass spectrometry.
The lyophilized powder is normally kept at minus twenty degrees Celsius or colder. Solutions are held at refrigerator temperature or below and protected from light. Repeated freezing and thawing is avoided because it can promote aggregation or loss of activity.